CBD’s GRAS status denied: FDA emits further warnings on compound’s legality amid safety concerns

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

The Center for Science in the Public Interest (CSPI) is urging the US Food and Drug Administration (FDA) to bring enforcement proceedings against companies that market... Read More

FormattedPicture

FOOD RESEARCH

Levagen+ is a potential sleeping aid capable of reducing sleep onset time and improving cognition upon waking. Levagen+ is a palmitoylethanolamide (PEA) powder, which... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based cannabis health and wellness company Open Book Extracts (OBX) is expanding its partnership with medical research company Radicle to launch what it says will be... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, a successful ingredient examination period resulted in in-process patents in Canada and South Korea of NattoPharma’s MenaQ7 Vitamin... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Norwegian vitamin K2 expert Kappa Bioscience launched a program to lower greenhouse emissions. Sabinsa increased its presence in the UK and... Read More

trans